Approval · Notice of Compliance 18693 · 2016
PLAN B: Notice of Compliance 18693
Issued November 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18693
- Date
- November 22, 2016
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of class labelling warning/contraindication statement
Products in this notice
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB
- LEVONORGESTREL 0.75 MG per TAB